AI Assistant
Blog
Pricing
Log In
Sign Up
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
